Zika vaccine Phase I trial to begin next month in India
Bharat Biotech International Ltd in Hyderabad will start a Phase I clinical trial of Zika virus vaccine (MR 766) in two centres in India next month. The inactivated vaccine being…
Category: Bharat Biotech International
Bharat Biotech’s Zika virus vaccine confers 100% protection in mice
The Hyderabad-based Bharat Biotech’s killed (inactivated) Zika virus vaccine using an African strain (MR 766) has shown 100% efficacy against mortality and disease in animal studies. A ‘killed virus vaccine’…
Indigenous vaccine against diarrhoea virus ‘safe’
A Phase III randomised, double-blind, placebo-controlled trial of 116E rotavirus vaccine undertaken in infants at three centres in India was found to be safe. It had modest efficacy of 56.4…
